FLONASE SENSIMIST OTC
Generic Name and Formulations:
Fluticasone furoate 27.5mcg; per nasal spray; scent- and alcohol-free.
Indications for FLONASE SENSIMIST:
Relieves symptoms of hay fever or other upper respiratory allergies. Ocular symptom relief (in patients ≥12yrs).
Initially 2 sprays in each nostril once daily for Week 1, then 1 or 2 sprays in each nostril once daily as needed for Week 2 through 6 months. Reevaluate after 6 months.
<2yrs: not recommended. Use for the shortest duration necessary to achieve response. ≥2–11yrs: 1 spray in each nostril once daily. Reevaluate after 2 months.
Not for treating asthma. Injury or surgery to nose that is not fully healed: not recommended. Discontinue if exposed to chicken pox, measles, or tuberculosis. Glaucoma. Cataracts. Discontinue if whistling sound from nose, visual disturbances, severe or frequent nosebleeds occur. Discontinue if no improvement within 7 days after starting or if new symptoms (eg, facial pain, nasal discharge) develop. Avoid eyes or mouth. Pregnancy. Nursing mothers.
Caution with concomitant ritonavir, ketoconazole, other steroids.
Stinging, sneezing, headaches, dry/irritated nose or throat, nosebleeds, whistling sound, blurred or reduced vision, reduced growth rate in children, allergic reaction (discontinue if occurs).
Spray—9.9mL (60 sprays); 15.8mL (120 sprays)
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Comparing Antidiabetic Drug Classes for Risk of Heart Failure
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Behavioral Weight Loss Interventions May Prevent Obesity
- Disaster Preparedness 101: Physician Resources for Patients
- Assessing the Environmental Impact of the Healthcare Industry
- Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom
- Clonidine Testing Is Safe and Reliable for Diagnosing Growth Hormone Deficiency